Background: Coronary Artery Disease (CAD) is the atherosclerosis of coronary arteries that carry blood to the heart muscle. Atherosclerosis is an inflammatory disease. Cytokine gene variations such as those associated with the IL1 family are involved in the pathogenesis of atherosclerosis.
Introduction
Atherosclerosis is an inflammatory disease that affects medium or large arteries causing gangrene, stroke and heart diseases. Coronary Artery Disease (CAD) is a multifactorial heart disease caused by atherosclerosis of coronary arteries 1 . Growth and clotting factors, cytokines, adhesion molecules and their effects on vascular Endothelial Cells (EC) and Smooth Muscle Cells (SMC) were studied for insight into atherosclerotic processes 2 . Inflammation in the artery wall triggers the production of primary proinflammatory cytokines such as Interleukin-1β (IL-1β), Tissue Necrosis Factor α (TNFα) which can induce the secondary proinflammatory cytokine (IL-6), the chemokine (IL-8), and adhesion molecule (E-selectin) production 3 .
The IL-1 family has three well-studied members, two agonists, IL-1α and IL-1β, and the antagonist IL-1Ra. IL1Ra inhibits IL-1-induced inflammation action by blocking the binding of IL-1 to IL-1 Type I Receptor (IL-1RI) 4 . IL-1Ra is expressing from IL1RN gene which has a length variation within intron 2 5 caused by 86 bp Variable Number of Tandem Repeats (VNTR) 6 . According to the number of 86 bp repeats, there are six alleles corresponding to 1, 2, 3, 4, 5, 6 repeats [6] [7] . Single nucleotide polymorphisms (SNPs) have been determined at promoter position -511 C/T 8 and in exon 5 at position +3953 C/T of IL1B gene 9 . These polymorphisms in IL1RN and IL1B genes are thought to influence gene expression [8] [9] .
There are various reports showing a relationship between VNTR and SNPs on the IL1 gene family and diseases. IL1RN genotype 2/2 has been found to be significantly associated with Single Vessel Disease (SVD) in Sheffield English population 10 . Significant relevance was found between IL1RN allele 2 and CAD with Type 2 diabetes 11 . Also IL1RN allele 2 has a protective effect on restenosis after Percutaneous Transluminal
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Coronary Angioplasty (PTCA) 12 . But no association was found between IL1B SNPs and CAD 10, 13 . The purpose of this study was to investigate whether polymorphisms in IL1RN (VNTR) and IL1B (-511, +3953) genes are associated with CAD in Turkey. Our results showed that neither IL1B (+3953) nor IL1B (-511) SNP genotype distributions and allele frequencies are susceptible to CAD, but people carrying IL1RN 2/2 genotype may be susceptible to SVD in the Turkish population.
Methods Subjects
The study population was selected from patients undergoing coronary angiography at Dr. Siyami Ersek Hospital between [2003] [2004] [2005] [2006] . Indications for coronary arteriography in our clinic are based on guidelines for coronary angiography 14 . According to coronary angiography results 12, 15 participants who presented ≥ 70 % stenoses in at least one of the major coronary arteries were considered as CAD (n= 257) and the remainders who presented ≤ 30 % stenosis were accepted in the normal group (n= 170). CAD group was divided into two subgroups: SVD (only one coronary artery stenosis; n= 91) and Multiple Vessel Disease (MVD; more than one coronary artery stenosis; n= 166).
Risk factor assessment
Age, gender, family history of CAD, smoking habit, history of hypertension were obtained by filling a questionnaire form. Weight, height, Systolic (SBP) and Diastolic Blood Pressures (DBP) were measured. Body Mass Index (BMI) was calculated from height and weight measurements. The presence of Diabetes Mellitus (DM) was defined by repeated fasting glucose level > glucose 126 mg/dl, the use of antidiabetic drugs or both. Total Cholesterol (TC) and High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL) cholesterol levels were determined enzymatically, and also measured enzymatically after dextrane sulfate magnesium precipitation 16 . Information about the study was given to all patients and control group, the informed consent was received from each of them.
Genotyping
Blood samples were taken from 427 participants and kept in tubes with EDTA. Genomic DNA isolation was done using GENTRA DNA isolation kit. We have amplified VNTR region in intron 2 of IL1RN gene, IL1B (-511) and IL1B (+3953 exon 5 regions as described previously 17 . Genotypes of IL1RN gene were determined by repeating unit size of PCR products. IL1B (-511) genotype was done based on the size of digested PCR products with AvaI, and IL1B (+3953) genotype was determined based on the digested PCR products with Taq I.
Statistical analysis
Mann-Whitney U and x 2 tests were used for the comparison of two groups of individuals according to CAD risk factors. Allele and genotype frequencies among cases and controls were compared with Hardy-Weinberg predictions using x 2 -analysis. Multivariate logistic regression analysis was done to assess the distribution of IL1RN, IL1B genotypes in the control groups and cases. The results were expressed as odds ratio (OR) and 95% Confidence Interval (CI). The final model was adjusted for age, gender, family history of CAD, smoking habit, history of hypertension. Allele frequencies and genotype distribution among cases and controls were compared and values were calculated by x 2 test. Probability for p<0.05 values (2-sided) were considered statistically significant. SPSS 11.5 software program was used for all statistical analysis.
Ethics approval
This research was approved by the ethics committee of Marmara University in Turkey. All human subjects' rights in this research are protected and any necessary approval was secured from the ethics committee.
Results
Baseline characteristics of control and CAD groups can be found in Table I . Significant difference between CAD and control subjects for gender (P= <0.001), family history of CAD (P= 0.014), Diabetes (P<0.001) History of Hypertension (P= <0.001) and current smoking (P= <0.001) can be found in Table 1 .
Genotype distribution and allele frequency of IL1RN VNTR are shown in Table 2 . Four of six genotypes at IL1RN gene were observed in CAD and control subjects. Among all these genotypes, only IL1RN 2/2 is significantly different Genotype distribution and allele frequency of IL1B (-511) in CAD, SVD, MVD and control groups are shown in Table  3 . The IL1B -511 genotype showed no significant difference between CAD and controls (P= 0.242), SVD and control (P= 0.712) and MVD and control (P= 0.142). Similarly, no significant differences were observed in allelic distribution between controls and CAD (P= 0.442), SVD (P= 0.098), and MVD (P= 0.142) ( Table 3 ).
The allelic frequency and genotype distribution of IL1B +3953 in CAD, SVD and MVD and control groups are shown in Table  4 . When genotype distribution of IL1B +3953 was compared among groups, no significant difference was observed between control groups and CAD (P= 0.629), SVD (P= 0.907), and MVD (P= 0.472). Also, no significant difference was observed in allelic distribution between controls and CAD (P= 0.569), SVD (P= 0.750) and MVD (P= 0.591) ( Table 4) .
Genotypes are expressed as number of patients (proportion in % within brackets), p values are from chi square test.
Homozygosity for IL1RN 2 allele was found significant between SVD and control groups (x 2 : 7.510, P= 0.010, OR: 3.253, % 95 CI: 1.349-7.844), However, this association can not be seen in heterozygosity for IL1RN 2 allele (P=0.757) ( Table 5) . Also, significant association was found in homozygosity for IL1RN 2 allele between MVD and SVD groups (x 2 : 7.160, P= 0.011, OR: 2.838, % 95 CI: 1.278-6.299); (Table 5) . Additionally, the relative effect of the IL1 family polymorphism on the risk of CAD was not seen in a multiple logistic regression model including dominant, recessive and co-dominant effects (Table 6 ).
Discussion
CAD is the major cause of mortality and morbidity in the United States, European countries and also in Turkey 18 . The etiology and development processes of CAD are not well understood, but it has been shown that both inflammation and genetics play an important role in the pathogenesis of atherosclerosis 2 . Many epidemiological studies have investigated the association between CAD and inflammatory cytokine gene polymorphisms 19 . One of the candidate proinflammatory cytokines associated with CAD susceptibility is IL-1β, which affects the majority of cells and is involved in immunity, sepsis, infection and inflammation. In contrast, IL-1Ra acts as an anti-inflammatory agent that inhibits the action of IL-1 20 .
Francis et al 10 found the association between IL-1RN 2/2 genotype and SVD in the UK Caucasian Sheffield population, but not in the London population. Also, no significant difference was found for MVD in either population group 10 . Other reports did not find any statistical significance between IL1RN 2 allele and SVD or IL1RN 2 allele and CAD 21, 13 . Furthermore, it has been reported that IL1RN 2 allele is significantly associated with CAD in the Type 2 diabetes patients 11 . Also, IL1RN 2 allele has a protective effect on restenosis after PTCA 12 and an association between IL1RN 2 and carotid atherosclerosis was reported 22 . It was also reported that future Myocardial Infarction risk was increased with IL1RN 2 allele and high CRP levels in young patients 23 . Table 5 ). Futhermore, we could not find any statistically significant influence of IL1 family polymorphisms (dominant, recessive and co-dominant effects) on the risk of CAD (Table 6 ). Even though IL1 family polymorphisms did not show any direct relative effect on risks of CAD, those polymorphisms may modulate some of processes for the development of CAD.
There appears to be a balance between IL-1 and IL-1Ra protein, except in the case of autoimmune diseases 24 . There are controversial results for the function of IL1RN 2 allele in IL-1Ra expression. It has been reported that IL1RN 2 allele is associated with increased IL-1Ra levels in vitro [25] [26] [27] , decreased levels in Ulcerative colitis 27 but at similar levels for South African patients with inflammatory bowel disease 28 . The results above imply that IL1RN 2 polymorphism function in affecting IL-1Ra protein expression depends on cell type and ethnic origin.
It has been suggested that IL-1β may play an important role in the pathogenesis of atherosclerosis by the stimulation of vascular SMC. Also, increased levels of IL-1β mRNA was detected in atherosclerotic plaques 29 . The polymorphisms in IL-1B gene can affect severity or susceptibility to different diseases. Two important SNPs at -511 C/T in the promoter and +3953 C/T in exon 5 of IL1B gene are shown respectively 8, 9 . Different controversial results have been reported for the effect of IL1B (-511) polymorphism on the production of IL1Ra and IL-1β. It has been reported that individuals who have IL1B (-511) allele 2 show higher levels of IL-1Ra 26 . LPS-induced IL-1β production was increased 2-3 fold by a T allele at -511 position 30 . No significant relationship between -511 alleles of IL1B and CAD has been determined 10, 13 . However, Iacoviello et al 31 indicated that the IL1B (-511) 1/1 (C/C) genotype was associated with MI at young age 31 . Similarly, Zhang et al 32 reported that IL1B (-511) polymorphism was associated to the severity of coronary heart disease in the Chinese population 32 . However, we did not find any risk for CAD related to IL1B (-511) polymorphism in the Turkish population. No significant differences were found in the frequencies of allele 1 and 2 or the genotypes of 1/1 and 2/2 of IL1B (-511) between SVD and control or MVD and control or CAD and control groups (Table 3) .
Another polymorphism in the IL1B gene is located at position +3953 in exon 5 and thought to influence IL-1β expression. Different results were reported on the effect of IL1B (+3953) allele on IL-1β protein production. Some studies showed that an association was seen between IL1B (+3953) and increased plasma levels of IL-1β 9, 30 , but others found no affect on IL-1 levels [33] [34] [35] . No studies are available on the relationship between CAD and polymorphism in the IL1B gene (+3953). No association was seen between either IL1B (+3953) allele frequency or genotype distribution and CAD in the British population 10 . Similarly, no relationship was found between CAD and IL1B (+3953) polymorphism in the Turkish population (Table 4 ).
The present study has shown that the homozygote carrier of IL-1RN allele 2 may be a risk factor for SVD. Controversial results were obtained for the association between IL1RN 2 and CAD from the different studies and different locations. This showed that ethnic background and different geographical locations play an important role for that association.
